日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn's Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III Trials

诱导治疗后达到内镜下缓解可减轻克罗恩病患者的住院负担：Risankizumab 和 Upadacitinib III 期试验的汇总事后分析结果

期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjae128
Panaccione, Remo; Ma, Christopher; Jairath, Vipul; Dignass, Axel; Joshi, Namita; Clark, Ryan; Griffith, Jenny; Kligys, Kristina; Semwal, Monika; Smith, Zachary; Mitchell, Dominic; Nunag, Dominic; Ferrante, Marc
克罗恩病
发表日期：2025
文献求助 收藏

Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn's Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies

Risankizumab 与克罗恩病患者生物标志物正常化相关：来自 3 期 ADVANCE、MOTIVATE 和 FORTIFY 研究的结果

期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjae164
Atreya, Raja; Ferrante, Marc; Panaccione, Remo; Feagan, Brian; Shchukina, Oksana; Jairath, Vipul; Rieder, Florian; Hisamatsu, Tadakazu; Siegmund, Britta; Kligys, Kristina; Song, Alexandra; Zambrano, Javier; Mallick, Madhuja; Zhang, Yafei; Armuzzi, Alessandro; D'Haens, Geert
克罗恩病
发表日期：2025
文献求助 收藏

Mucosal and Transmural Healing and Long-term Outcomes in Crohn's Disease

克罗恩病黏膜和全层愈合及长期预后

期刊:Inflammatory Bowel Diseases
影响因子:4.3
doi:10.1093/ibd/izae159
Sands, Bruce E; Danese, Silvio; Chapman, J Casey; Gurjar, Khushboo; Grieve, Stacy; Thakur, Deepika; Griffith, Jenny; Joshi, Namita; Kligys, Kristina; Dignass, Axel
克罗恩病
发表日期：2025
文献求助 收藏

Induction of Endoscopic Response, Remission, and Ulcer-Free Endoscopy With Upadacitinib Is Associated With Improved Clinical Outcomes and Quality of Life in Patients With Crohn's Disease

使用乌帕替尼诱导克罗恩病患者的内镜反应、缓解和无溃疡内镜检查结果，可改善患者的临床结局和生活质量。

期刊:Inflammatory Bowel Diseases
影响因子:4.3
doi:10.1093/ibd/izae200
Panés, Julian; Louis, Edouard; Bossuyt, Peter; Joshi, Namita; Lee, Wan-Ju; Lacerda, Ana P; Kligys, Kristina; Xuan, Si; Shukla, Nidhi; Loftus, Edward V Jr
克罗恩病
发表日期：2025
文献求助 收藏

Early Endoscopic Outcomes After Risankizumab Are Associated With Fewer Hospitalizations and Surgeries in Crohn's Disease

利沙珠单抗治疗后早期内镜检查结果与克罗恩病患者住院和手术次数减少相关

期刊:Gastro Hep Advances
影响因子:
doi:10.1016/j.gastha.2024.08.022
Feagan, Brian G; Colombel, Jean-Frederic; Panaccione, Remo; Schreiber, Stefan; Ferrante, Marc; Kamikozuru, Koji; Ma, Christopher; Lee, Wan-Ju; Griffith, Jenny; Joshi, Namita; Kligys, Kristina; Kalabic, Jasmina; Xuan, Si; Dubinsky, Marla
克罗恩病
发表日期：2025
文献求助 收藏

Effect of Risankizumab Induction and Maintenance Therapy on the Rate of Hospitalization in Patients with Crohn's Disease

利沙珠单抗诱导和维持治疗对克罗恩病患者住院率的影响

期刊:Gastro Hep Advances
影响因子:
doi:10.1016/j.gastha.2024.100603
Feagan, Brian G; Panaccione, Remo; Schreiber, Stefan; Loftus, Edward V Jr; Peyrin-Biroulet, Laurent; Arai, Takehiro; Lee, Wan-Ju; Griffith, Jenny; Kalabic, Jasmina; Kligys, Kristina; Xuan, Si; Liao, Xiaomei; Ferrante, Marc
克罗恩病
发表日期：2025
文献求助 收藏

Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn's Disease

乌帕替尼诱导和维持治疗对中重度活动性克罗恩病患者的健康相关生活质量、疲劳和工作效率的影响

期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjae083
Ghosh, Subrata; Feagan, Brian G; Parra, Rogério Serafim; Lopes, Susana; Steinlauf, Adam; Kakuta, Yoichi; Joshi, Namita; Lee, Wan-Ju; Lacerda, Ana P; Zhou, Qian; Xuan, Si; Kligys, Kristina; Shukla, Nidhi; Louis, Edouard
克罗恩病
发表日期：2024
文献求助 收藏

Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn's Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies

Risankizumab诱导治疗可早期改善克罗恩病患者的症状，且这些症状与未来的临床和内镜结果相关：ADVANCE、MOTIVATE和FORTIFY 3期研究的事后分析

期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjad206
Colombel, Jean-Frederic; Schreiber, Stefan; D'Haens, Geert; Rizzo, Joanne; Kligys, Kristina; Griffith, Jenny; Zambrano, Javier; Zhou, Qian; Zhang, Yafei; Kalabic, Jasmina; Rieder, Florian; Dubinsky, Marla C; Panaccione, Remo
克罗恩病
发表日期：2024
文献求助 收藏

Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial

在一项随机3期试验中，Risankizumab维持治疗可维持克罗恩病患者的诱导反应。

期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjad168
Ferrante, Marc; Irving, Peter M; Abreu, Maria T; Axler, Jeffrey; Gao, Xiang; Cao, Qian; Fujii, Toshimitsu; Rausch, Astrid; Torres, Joana; Neimark, Ezequiel; Song, Alexandra; Wallace, Kori; Kligys, Kristina; Berg, Sofie; Liao, Xiaomei; Zhou, Qing; Kalabic, Jasmina; Feagan, Brian; Panaccione, Remo
克罗恩病
发表日期：2024
文献求助 收藏

Shorter Crohn's Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies

克罗恩病病程较短与Risankizumab治疗在3期临床试验中取得更好的临床和内镜疗效相关。

期刊:Gastro Hep Advances
影响因子:
doi:10.1016/j.gastha.2024.02.008
Peyrin-Biroulet, Laurent; Colombel, Jean-Frederic; Louis, Edouard; Ferrante, Marc; Motoya, Satoshi; Panaccione, Remo; Torres, Joana; Ungaro, Ryan C; Kligys, Kristina; Kalabic, Jasmina; Zambrano, Javier; Zhang, Yafei; D'Haens, Geert
克罗恩病
发表日期：2024
文献求助 收藏